3 718

Cited 40 times in

Osteonecrosis of the jaw related to everolimus: a case report

DC Field Value Language
dc.contributor.author박형식-
dc.contributor.author정영수-
dc.contributor.author정휘동-
dc.contributor.author김동욱-
dc.date.accessioned2014-12-18T09:40:50Z-
dc.date.available2014-12-18T09:40:50Z-
dc.date.issued2013-
dc.identifier.issn0266-4356-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/88625-
dc.description.abstractAntiresorptive agent-related osteonecrosis of the jaw results in appreciable morbidity in affected patients. Nowadays many physicians prescribe an antiangiogenic agent for the management of malignant metastases. Everolimus is a serine-threonine kinase that acts as an inhibitor of mammalian target of rapamycin, which results in reduced growth of cells, angiogenesis, and survival of cells. We report the first case to our knowledge of osteonecrosis of the jaw that seemed to result from the additive effect of everolimus.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfBRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAngiogenesis Inhibitors/adverse effects*-
dc.subject.MESHBone Density Conservation Agents/therapeutic use-
dc.subject.MESHBone Neoplasms/drug therapy-
dc.subject.MESHBone Neoplasms/secondary-
dc.subject.MESHDiphosphonates/therapeutic use-
dc.subject.MESHEverolimus-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHHumans-
dc.subject.MESHImidazoles/therapeutic use-
dc.subject.MESHMale-
dc.subject.MESHMandibular Diseases/chemically induced*-
dc.subject.MESHMiddle Aged-
dc.subject.MESHOsteonecrosis/chemically induced*-
dc.subject.MESHSirolimus/adverse effects-
dc.subject.MESHSirolimus/analogs & derivatives*-
dc.subject.MESHThyroid Neoplasms/surgery-
dc.subject.MESHThyroidectomy/methods-
dc.titleOsteonecrosis of the jaw related to everolimus: a case report-
dc.typeArticle-
dc.contributor.collegeCollege of Dentistry (치과대학)-
dc.contributor.departmentDept. of Oral and Maxillofacial Surgery (구강악안면외과학)-
dc.contributor.googleauthorDong Wook Kim-
dc.contributor.googleauthorYoung-Soo Jung-
dc.contributor.googleauthorHyung-Sik Park-
dc.contributor.googleauthorHwi-Dong Jung-
dc.identifier.doi10.1016/j.bjoms.2013.09.008-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01755-
dc.contributor.localIdA03655-
dc.contributor.localIdA03792-
dc.relation.journalcodeJ00413-
dc.identifier.eissn1532-1940-
dc.identifier.pmid24094895-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0266435613004269-
dc.subject.keywordARONJ-
dc.subject.keywordAnti-angiogenic agent-
dc.subject.keywordAnti-resorptive agent related osteonecrosis of the jaw-
dc.subject.keywordEverolimus-
dc.contributor.alternativeNamePark, Hyung Sik-
dc.contributor.alternativeNameJung, Young Soo-
dc.contributor.alternativeNameJung, Hwi Dong-
dc.contributor.affiliatedAuthorPark, Hyung Sik-
dc.contributor.affiliatedAuthorJung, Young Soo-
dc.contributor.affiliatedAuthorJung, Hwi Dong-
dc.rights.accessRightsnot free-
dc.citation.volume51-
dc.citation.number8-
dc.citation.startPage302-
dc.citation.endPage304-
dc.identifier.bibliographicCitationBRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, Vol.51(8) : 302-304, 2013-
dc.identifier.rimsid33364-
dc.type.rimsART-
Appears in Collections:
2. College of Dentistry (치과대학) > Dept. of Oral and Maxillofacial Surgery (구강악안면외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.